Cargando…
Personalising cancer medicine with prognostic markers
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477141/ https://www.ncbi.nlm.nih.gov/pubmed/34563926 http://dx.doi.org/10.1016/j.ebiom.2021.103577 |
| _version_ | 1784575782973079552 |
|---|---|
| author | Kerr, David J Yang, Li |
| author_facet | Kerr, David J Yang, Li |
| author_sort | Kerr, David J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8477141 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84771412021-10-04 Personalising cancer medicine with prognostic markers Kerr, David J Yang, Li EBioMedicine Commentary Elsevier 2021-09-23 /pmc/articles/PMC8477141/ /pubmed/34563926 http://dx.doi.org/10.1016/j.ebiom.2021.103577 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Commentary Kerr, David J Yang, Li Personalising cancer medicine with prognostic markers |
| title | Personalising cancer medicine with prognostic markers |
| title_full | Personalising cancer medicine with prognostic markers |
| title_fullStr | Personalising cancer medicine with prognostic markers |
| title_full_unstemmed | Personalising cancer medicine with prognostic markers |
| title_short | Personalising cancer medicine with prognostic markers |
| title_sort | personalising cancer medicine with prognostic markers |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477141/ https://www.ncbi.nlm.nih.gov/pubmed/34563926 http://dx.doi.org/10.1016/j.ebiom.2021.103577 |
| work_keys_str_mv | AT kerrdavidj personalisingcancermedicinewithprognosticmarkers AT yangli personalisingcancermedicinewithprognosticmarkers |